US Transcatheter Embolization and Occlusion Devices Market Research Report By Device Type (Coils, Particles, Gels, Liquid Embolic Agents), By Application (Uterine Artery Embolization, Tumor Embolization, Devascularization Procedures, Hemorrhage Control), By End User (Hospitals, Ambulatory Surgical Centers, Specialized Clinics) and By Technique (Transcatheter Embolization, Surgical Embolization) - Forecast to 2035

US Transcatheter Embolization and Occlusion Devices Market Overview

As per MRFR analysis, the US Transcatheter Embolization and Occlusion Devices Market Size was estimated at 561.05 (USD Million) in 2023. The US Transcatheter Embolization and Occlusion Devices Market Industry is expected to grow from 614.95 (USD Million) in 2024 to 1,380.36 (USD Million) by 2035. The US Transcatheter Embolization and Occlusion Devices Market CAGR (growth rate) is expected to be around 7.627% during the forecast period (2025 - 2035).

Key US Transcatheter Embolization and Occlusion Devices Market Trends Highlighted

The US Transcatheter Embolization and Occlusion Devices Market is witnessing significant growth due to several key market drivers. Increasing incidences of vascular diseases, coupled with a rising aging population in the US, is driving demand for minimally invasive procedures. Healthcare providers are increasingly adopting transcatheter techniques as these procedures typically result in quicker recovery times and reduced hospital stays. Additionally, advancements in technology have led to the development of innovative devices that are more effective and user-friendly, which further supports market growth. Opportunities within the US market also point towards the potential for expansion. There is an increasing focus on research and development, with various institutions exploring new embolization materials and devices aimed at improving patient outcomes. Regulatory support from US health authorities encourages the introduction of new technologies. Furthermore, the rise of telemedicine and remote monitoring presents an avenue for healthcare professionals to engage with patients undergoing embolization procedures, allowing for better follow-up care, which can enhance patient satisfaction.

Trends in recent times reflect a growing awareness and acceptance of transcatheter embolization as an effective treatment option among both physicians and patients in the US. A notable shift towards personalized medicine is influencing device manufacturers to create customized solutions for specific conditions. Additionally, hospitals and clinics are increasingly partnering with device manufacturers for training and support, ensuring better device utilization and patient management. As more healthcare institutions recognize the benefits of these technologies, the market is likely to continue on a growth trajectory, driven by these evolving trends and emerging opportunities.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Transcatheter Embolization and Occlusion Devices Market Drivers

Rising Incidence of Cancer and Vascular Diseases

The US Transcatheter Embolization and Occlusion Devices Market Industry is experiencing significant growth due to the increasing incidence of cancer and vascular diseases. According to the American Cancer Society, an estimated 1.9 million new cancer cases are expected to be diagnosed in the United States in 2023. As the demand for less invasive treatment options grows, transcatheter embolization devices become more sought after for procedures like tumor embolization and treatment of vascular malformations. Furthermore, the Centers for Disease Control and Prevention reported that nearly 84 million adults in the US are living with cardiovascular diseases. This alarming trend drives healthcare providers to seek advanced embolization and occlusion solutions, allowing for better patient outcomes while minimizing recovery times. Notable organizations like Medtronic and Boston Scientific are actively investing in Research and Development to enhance their product offerings in this segment, thereby contributing to the expansion of the US Transcatheter Embolization and Occlusion Devices Market.

Technological Advancements in Medical Devices

Technological advancements in medical device manufacturing are a significant driver of the US Transcatheter Embolization and Occlusion Devices Market Industry. Innovations in catheter technology, materials, and imaging techniques have improved procedural efficacy and safety. The FDA has accelerated the approval process for new medical devices, evidenced by an increase in the number of approved devices in recent years. In 2022, over 1,000 devices were approved by the FDA for various applications, including embolization. Companies such as Stryker and Abbott Laboratories are leading these advancements, creating products that allow for improved precision during embolization procedures. This increased technological capability will directly correlate with market growth as healthcare professionals increasingly adopt these new solutions.

Growth in the Geriatric Population

The aging population in the United States is a crucial factor affecting the growth of the US Transcatheter Embolization and Occlusion Devices Market Industry. According to the U.S. Census Bureau, the number of Americans aged 65 and older is projected to reach over 95 million by 2060, nearly double from 2015 figures. This demographic is more susceptible to conditions requiring transcatheter embolization, such as cardiovascular diseases and tumors. The growing geriatric population results in a higher demand for innovative and effective treatment options that transcatheter embolization devices can provide. With established companies like Johnson & Johnson and Cook Medical focusing on addressing the unique healthcare needs of older adults, the advancement and adoption of embolization technologies are set to rise sharply.

Increasing Investment in Healthcare Infrastructure

Increasing investment in healthcare infrastructure in the United States significantly bolsters the US Transcatheter Embolization and Occlusion Devices Market Industry. The American Hospital Association states that hospitals have invested over $45 billion in capital projects to expand services, including interventional radiology departments that utilize embolization techniques. With government initiatives and healthcare reforms aimed at improving accessibility and quality of care, hospitals and clinics are more likely to acquire advanced embolization technology. This influx of investment supports the development of advanced healthcare facilities equipped with cutting-edge devices, ultimately driving the growth of the market. Major players like Siemens Healthineers are collaborating with healthcare facilities to enhance their service capabilities, further influencing market dynamics.

US Transcatheter Embolization and Occlusion Devices Market Segment Insights

Transcatheter Embolization and Occlusion Devices Market Device Type Insights

The US Transcatheter Embolization and Occlusion Devices Market demonstrates a robust framework that focuses on various device types, which are crucial for medical professionals engaged in vascular treatments and interventions. Among these, coils are widely recognized for their effectiveness in occluding blood vessels, particularly in procedures involving aneurysms and arteriovenous malformations. Their ease of use, along with a high success rate in achieving hemostasis, makes them essential tools in interventional radiology. Particles, on the other hand, are often applied in tumor embolization and achieving localized treatment effects. Their size and bio-compatibility enhance efficacy and minimize adverse reactions, catering to the growing demand for targeted therapies in the US healthcare landscape.

Gels play a significant role in the embolization process, as they accord practitioners greater control over blood flow disruption, with their flow characteristics allowing more versatile applications in various anatomical contexts. Furthermore, liquid embolic agents have emerged as vital components, especially in complex cases where accessibility or conditions require intricate management. These agents can solidify in situ to create barriers against vascular flow, proving highly effective in more challenging clinical situations. Each device type not only contributes uniquely to the operational capabilities of healthcare providers but also influences current market trends driven by advancements in minimally invasive techniques, thus enhancing the overall efficacy of intervention strategies in the US Transcatheter Embolization and Occlusion Devices Market. Moreover, the consistent innovation in device materials and designs continues to foster growth opportunities in the field as healthcare systems increasingly adapt to the growing demand for precision medicine, highlighting the importance of understanding the complexities within the US Transcatheter Embolization and Occlusion Devices Market segmentation by device type.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Transcatheter Embolization and Occlusion Devices Market Application Insights

The US Transcatheter Embolization and Occlusion Devices Market focuses on various critical applications, highlighting its integral role in advanced medical procedures. Uterine Artery Embolization is significant due to its efficacy in treating fibroids, a common condition affecting many women in the U.S., making it a pivotal area. Tumor Embolization is equally notable, being crucial in cancer management, offering a minimally invasive alternative to traditional surgery for tumor reduction and management, which aligns with the growing trend towards less invasive interventions in the US healthcare system. Devascularization Procedures serve an essential purpose in various surgical settings, assisting in reducing blood flow to organs and tissues, and are often vital in preparing patients for surgeries by minimizing blood loss. Hemorrhage Control remains a priority in emergency medicine, providing effective solutions for trauma and surgical patients, thereby improving patient outcomes. The presence of a robust population seeking these procedures, along with continued advancements in medical technology, propels growth in these application areas within the US Transcatheter Embolization and Occlusion Devices Market, as healthcare providers and patients pursue effective, safe, and innovative treatment options.

Transcatheter Embolization and Occlusion Devices Market End User Insights

The End User segment of the US Transcatheter Embolization and Occlusion Devices Market plays a significant role in the overall dynamics of the industry. This segment primarily includes Hospitals, Ambulatory Surgical Centers, and Specialized Clinics, each contributing uniquely to the provision of care and treatment options. Hospitals are often the leading providers due to their extensive resources, advanced technology, and specialized medical personnel, making them crucial for complex procedures. Ambulatory Surgical Centers have gained traction due to their ability to offer outpatient procedures, enhancing patient convenience and reducing hospital stays, thus driving demand for transcatheter embolization devices. Specialized Clinics, focusing on niche areas of care, are vital for focused treatment and follow-up, ensuring high-quality outcomes for patients. Together, these end users create a framework that not only supports market growth through increased adoption and accessibility but also reflects the evolving healthcare landscape in the US, where patient-centric approaches and minimally invasive techniques are becoming predominant. The US government has also shown support for technological advancements and innovative care models, facilitating further advancements in this market sector.

Transcatheter Embolization and Occlusion Devices Market Technique Insights

The Technique segment within the US Transcatheter Embolization and Occlusion Devices Market plays a critical role in the overall framework of cardiovascular and interventional procedures. This segment primarily comprises Transcatheter Embolization and Surgical Embolization, both of which are essential for treating various conditions such as vascular malformations and tumors. Transcatheter Embolization has gained significant traction due to its minimally invasive nature, allowing for reduced recovery times and lower risk of complications. Meanwhile, Surgical Embolization continues to hold its place as a reliable method in more complex cases, where direct access to the affected area is needed. The growth in these techniques is driven by the increasing prevalence of conditions requiring embolization and the technological advancements that enhance procedural efficacy. Additionally, evolving healthcare policies and an increasing shift towards outpatient treatments in the US are contributing to the segment's prominence. As healthcare providers focus on improving patient outcomes and minimizing hospital stays, the Technique segment is expected to remain significant in the coming years, showcasing continued innovation and adoption.

US Transcatheter Embolization and Occlusion Devices Market Key Players and Competitive Insights

The US Transcatheter Embolization and Occlusion Devices Market is characterized by a competitive landscape with a plethora of players striving to gain larger market shares through innovative product offerings and strategic collaborations. This sector, which is essential for minimally invasive procedures involving the occlusion of blood vessels, is witnessing a surge in demand due to the rising incidence of various diseases requiring embolization. The market is also bolstered by technological advancements and an increasing focus on improving patient outcomes. The competitive insights reflect a mix of established companies and emerging players, each leveraging unique strengths to capture consumer interest. Key factors influencing competition include product efficacy, safety, regulatory approvals, and market accessibility, leading to an environment of dynamic interactions among competitors in the industry.

Merit Medical Systems has established itself as a formidable player in the US Transcatheter Embolization and Occlusion Devices Market through an extensive portfolio of innovative medical devices designed to meet the diverse needs within this specific segment. The company's strengths lie in its commitment to research and development, helping it create advanced embolization solutions that cater to various clinical indications. Merit Medical Systems differentiates itself through its focus on quality and reliability, which enhances trust among healthcare professionals and patients alike. Additionally, by maintaining a robust distribution network and fostering relationships with hospitals and healthcare providers, the company has successfully positioned itself as a go-to resource for embolization and occlusion devices in the US.

Terumo Corporation represents another key competitor in the US Transcatheter Embolization and Occlusion Devices Market, known for its wide range of high-quality medical products and innovative approaches in vascular intervention. Terumo's portfolio includes advanced embolization coils, vascular access systems, and balloon occlusion devices, which are vital for effective transcatheter procedures. The company is recognized for its strong presence and market penetration in the US, complemented by its commitment to continuous innovation and superior customer service. Terumo Corporation's strengths include its strategic emphasis on R&D, which has led to the introduction of cutting-edge technologies that enhance procedural efficiency and patient outcomes. Through various partnerships and potential mergers and acquisitions, Terumo remains poised to expand its influence and enhance its offerings in the embolization space, ensuring its competitive stance within the market.

Key Companies in the US Transcatheter Embolization and Occlusion Devices Market Include

• Merit Medical Systems


• Terumo Corporation


• Medtronic


• Boston Scientific


• Abbott Laboratories


• Phillips Healthcare


• Livanova


• Cardinal Health


• Stryker Corporation


• Cook Medical


• B. Braun Melsungen


• Penumbra


• Asahi Intecc


• Johnson and Johnson

US Transcatheter Embolization and Occlusion Devices Market Industry Developments

Recent developments in the US Transcatheter Embolization and Occlusion Devices Market indicate a robust growth trajectory, attributed to increased procedural volumes and advancements in technology. Companies such as Merit Medical Systems, Terumo Corporation, and Medtronic are actively enhancing their product portfolios through innovative designs and improved materials. As of September 2023, Boston Scientific launched a new embolization device aimed at improving safety and efficacy in transcatheter procedures, further solidifying its market position. Abbott Laboratories also reported growth in its vascular portfolio, showing a strong presence in the embolization space. Current affairs highlight an ongoing focus on mergers and acquisitions, with Terumo Corporation acquiring a significant stake in a US-based medical device firm in July 2023 to bolster its embolization technologies. The market has seen the entrance of new players, influenced by favorable regulations and an increasing prevalence of conditions requiring embolization. Over the past few years, the US market has also experienced an uptick in demand for minimally invasive procedures, as patients increasingly prefer options that offer reduced recovery times. This trend is expected to continue, fostering further investments and innovations in the sector.

US Transcatheter Embolization and Occlusion Devices Market Segmentation Insights

Transcatheter Embolization and Occlusion Devices Market Device Type Outlook

• Coils


• Particles


• Gels


• Liquid Embolic Agents

Transcatheter Embolization and Occlusion Devices Market Application Outlook

• Uterine Artery Embolization


• Tumor Embolization


• Devascularization Procedures


• Hemorrhage Control

Transcatheter Embolization and Occlusion Devices Market End User Outlook

• Hospitals


• Ambulatory Surgical Centers


• Specialized Clinics

Transcatheter Embolization and Occlusion Devices Market Technique Outlook

• Transcatheter Embolization


• Surgical Embolization

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	561.05(USD Million)
MARKET SIZE 2024	614.95(USD Million)
MARKET SIZE 2035	1380.36(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.627% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Merit Medical Systems, Terumo Corporation, Medtronic, Boston Scientific, Abbott Laboratories, Phillips Healthcare, Livanova, Cardinal Health, Stryker Corporation, Cook Medical, B. Braun Melsungen, Penumbra, Asahi Intecc, Johnson and Johnson
SEGMENTS COVERED	Device Type, Application, End User, Technique
KEY MARKET OPPORTUNITIES	Minimally invasive surgery demand, Increasing aging population, Technological advancements in devices, Rising prevalence of vascular diseases, Growing awareness and training programs
KEY MARKET DYNAMICS	rising prevalence of vascular diseases, increasing number of minimally invasive procedures, technological advancements in device design, growing geriatric population, favorable reimbursement policies
COUNTRIES COVERED	US